Python libraries that replace hundreds of lines of custom code. LiteLLM, Instructor, Tenacity, and 5 more I use in every ...

A new perspective argues that a rich class of probability models known as Markov modulated models could transform how ...

In the high-tech, high-competition AI field, we are seeing new versions of models rolled out by the frontier companies (OpenAI, Google and Anthropic) every month and a half. I included a Release ...

Exponent demonstrates strong demand recovery, with Q2 revenue before reimbursement up 12% to $148.9M and EBITDA margin rising to 28.7%. I see sustainable growth potential, but hiring discipline and ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Ask a roomful of senior executives what AI can do for their business, and the answers will probably cluster around the same themes: lower costs, smaller headcount, faster processes, leaner operations.

Gen Z might be using the abbreviation for “point of view” incorrectly. But linguists think it’s exciting. By Nitsuh Abebe Two months ago, Griffin Bassett uploaded one of the language-education videos ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...